Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | BCHE | P06276 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL30536669 | 0.97 | KMT2A (0.52) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| SCHEMBL15571863 | 0.97 | KMT2A (0.52) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| SCHEMBL15571095 | 0.97 | KMT2A (0.52) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| Bromide SCHEMBL11429835 | 0.97 | KMT2A (0.58) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| Iodide SCHEMBL11884469 | 0.97 | KMT2A (0.52) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| SCHEMBL15571880 | 0.97 | KMT2A (0.52) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| Hydrochloric Acid SCHEMBL344009 | 0.97 | KMT2A (0.52) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| SCHEMBL15571321 | 0.97 | KMT2A (0.52) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| Hydrazine SCHEMBL9553603 | 0.92 | KMT2A (0.48) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| Betaine SCHEMBL3642873 | 0.82 | TSHR (0.56) | KMT2APABPC1KDM4EHSP90AA1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250228893-A1 | BROAD SPECTRUM ANTISEPTIC NANO EMULSION BASED ON A COMBINATION OF IONIC LIQUID AND COPPER NANOCLUSTERS | SINGH PAUL INDERESHWAR (IN) | 2025-07-17 | — | — | US | claimed |
| US-20250185665-A1 | DISINFECTANT AND METHODS OF PREPARATION THEREOF | PAUL UDAY DIDAR SINGH (IN) | 2025-06-12 | — | — | US | claimed |
| CN-118302153-A | Broad-spectrum antibacterial nanoemulsion based on combination of ionic liquid and copper nanoclusters | 英德尔施瓦·辛格·保罗 | 2024-07-05 | — | — | CN | claimed |
| CN-117367901-A | In-situ derivatization of cholesterol in tissue sections and MALDI mass spectrometry imaging method and application thereof | 中国科学院大连化学物理研究所 | 2024-01-09 | — | — | CN | claimed |
| WO-2023181062-A1 | DISINFECTANT AND METHODS OF PREPARATION THEREOF | PAUL UDAY DIDAR SINGH (IN) | 2023-09-28 | — | — | WO | claimed |
| CN-116103711-A | Forward and reverse pulse electrolytic nickel-phosphorus alloy solution, preparation method, electroplating method and nickel-phosphorus alloy coating | 安徽智备工业科技有限公司 | 2023-05-12 | — | — | CN | claimed |
| WO-2023067629-A1 | BROAD SPECTRUM ANTISEPTIC NANO EMULSION BASED ON A COMBINATION OF IONIC LIQUID AND COPPER NANOCLUSTERS | SINGH PAUL INDERESHWAR (IN) | 2023-04-27 | — | — | WO | claimed |
| CN-105951144-A | Nickel plating process for deep-hole part | 贵州振华群英电器有限公司（国营第八九厂） | 2016-09-21 | — | — | CN | claimed |
| EP-1021528-B1 | METHODS OF REFOLDING PROTEINS BY USE OF ZWITTERIONIC LOW MOLECULAR WEIGHT AGENTS | INST GENETICS LLC (US) | 2004-01-28 | — | — | EP | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0657544-B1 | Process for preparing optically active glycidate esters | SEPRACOR INC (US) | 1997-12-29 | — | — | EP | claimed |
| EP-0615855-B1 | Recording sheets containing pyridinium and/or piperazinum compounds | XEROX CORP (US) | 1997-05-14 | — | — | EP | claimed |
| EP-0657544-A1 | Process for preparing optically active glycidate esters | SEPRACOR, INC. (US) | 1995-06-14 | — | — | EP | claimed |
| US-4533730-A | BACTERICIDES | SHIONOGI & CO., LTD. (JP) | 1985-08-06 | — | — | US | claimed |
| US-4443598-A | ANTIBIOTICS AND INTERMEDIATES | SHIONOGI & CO., LTD. (JP) | 1984-04-17 | — | — | US | claimed |
| US-4366316-A | FROM OXAZOLINOAZETIDINONE AND ACID | SHIONOGI & CO., LTD. (JP) | 1982-12-28 | — | — | US | claimed |
| US-4086423-A | CEPHALOSPORINS, CYCLOADDITION OF GLYCINE DERIVATIVE TO THIAZINE COMPOUND | MERCK & CO., INC. (US) | 1978-04-25 | — | — | US | claimed |
| US-12584190-B2 | Methods for selective recovery of rare earth elements and metals from coal ash by ionic liquids | GEORGIA TECH RESEARCH CORPORATION (US) | 2026-03-24 | — | — | US | disclosed |
| US-4366316-A | FROM OXAZOLINOAZETIDINONE AND ACID | SHIONOGI & CO., LTD. (JP) | 1982-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12584190-B2 | Methods for selective recovery of rare earth elements and metals from coal ash by ionic liquids | CA2, ASH2L, CA1 | KMT2A 2342/4885PABPC1 1704/4885KDM4E 2355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.